Skip to content

Difference of Tear Ferning Between Women with and Without Menopausal.

Difference of Tear Ferning Between Pre-and Post-menopausal Women and Between Post-menopausal Women with or Without Hormone Replacement Therapy (HRT)

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06848829
Enrollment
90
Registered
2025-02-27
Start date
2024-10-01
Completion date
2025-10-01
Last updated
2025-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry Eye Syndromes

Keywords

Dry Eye diagnosis, Tear ferning, menopause

Brief summary

Application of tear ferning test for clinical dry eye diagnosis and menopause

Detailed description

Analyzing the difference in tear ferning structure between women pre and post-menopause with and without hormone replacement therapy (HRT). Tear and blood samples were collected for a menopause-related Enzyme-linked immunosorbent assay. Tear volume, tear osmolarity, intraocular pressure, and tear break-up time were also measured for comparison.

Interventions

OTHERPre-manepausal women

Compare tear ferning structure between pre-menopause and post-menopause women.

Sponsors

Chung Shan Medical University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Aged between 20 and 65 years

Exclusion criteria

* No evident ocular diseases such as cornea, cataracts, vitreous degeneration, glaucoma, and retinopathy. * Belong to vulnerable groups(pregnancy woman, prisoner, ethical minorities, economic or educationally disadvantaged subjects, disabled individuals such as those at terminal stage of tumorigenesis, blindness, terminal ill individuals)

Design outcomes

Primary

MeasureTime frameDescription
Tear film breakup time20 secondsTo assess tear quality
Tear ferning30 minutescrystal structure formed from tear drops on a slide be scored.
Menopause related hormone Enzyme-linked immunosorbent assay (ELISA)3 hoursTo assess FSH/LH/E2/Progesterone/Mc5AC/Lactoferrin concentration between pre- and post-manopause women.
Schirmer's test5 minutesTo assess tear secretion volume
Ocular surface status3 minutesTo assess ocular surface health status with lissamine green stain, health or corneal abrasion.

Secondary

MeasureTime frameDescription
Intraocular pressure2 minutesTo determine the effects of intervention on intraocular pressure
Ocular surface disease index20 minutesA questionnaire to assess the health status on ocular surface A final score is calculated which ranges from 0 to 100 with scores 0 to 12 representing normal, 13 to 22 representing mild dry eye disease, 23 to 32 representing moderate dry eye disease, and greater than 33 representing severe dry eye disease.

Countries

Taiwan

Contacts

Primary ContactDavid P Lin, PhD
pcl@csmu.edu.tw886-910-371286
Backup ContactYiting Tian, Master
s1000158@gmail.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026